Financial News
Latest News about MRK
Recent news which mentions MRK
What's Going On With C4 Therapeutics Stock?
December 15, 2023
From Benzinga
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
From Benzinga
MRNA Stock Surges as Moderna Teams Up With Merck to Fight Cancer
December 14, 2023
From InvestorPlace
Moderna CEO Highlights Promising Cancer Vaccine Data: 'Think About The Number Of Lives That Can Be Impacted'
December 14, 2023
From Benzinga
Moderna’s stock boosted by positive data from trial of melanoma treatment combined with Merck’s Keytruda
December 14, 2023
From MarketWatch
Why Is Moderna (MRNA) Stock Up 11% Today?
December 14, 2023
From InvestorPlace
Moderna Stock Is Soaring Today - Here's Why
December 14, 2023
From Benzinga
Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?
December 14, 2023
From Motley Fool
Dow Jones Skyrockets To Record Heights, Shatters 37,000 Mark, Fueled By Fed's Dovish Stance
December 13, 2023
From Benzinga
What's Going On With Moderna Stock Today?
December 12, 2023
From Benzinga
Why Is C4 Therapeutics (CCCC) Stock Up 72% Today?
December 12, 2023
From InvestorPlace
Why Is Cancer-Focused C4 Therapeutics Stock Soaring Today?
December 12, 2023
From Benzinga
Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer
December 08, 2023
From Benzinga
5 Dividend Stocks That Recently Increased Their Payouts
December 06, 2023
From Motley Fool
From Benzinga
Merck Highlights Data On New Vaccine, Compares 'Tolerability And Safety' To Pfizer's
November 28, 2023
From Benzinga
Stability Seekers: 7 Low-Volatility Stocks for Uncertain Times
November 23, 2023
From InvestorPlace
Merck's Caraway Deal: Analyst Says "Timely, Anchored By Novel Programs & Management Team"
November 22, 2023
Tickers
MRK
From Benzinga
These ten stocks, not just from tech, are the key to next year’s S&P 500 earnings growth
November 21, 2023
From MarketWatch
Merck's Latest Drug For Chronic Cough Faces FDA Pushback
November 18, 2023
From Benzinga
FDA Approves Merck's Blockbuster Cancer Drug For Type Of Gastric Cancer
November 17, 2023
Tickers
MRK
From Benzinga
Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits
November 17, 2023
From Benzinga
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion
November 17, 2023
From Benzinga
Merck's Gefapixant Under FDA Lens: Advisory Committee To Discuss Chronic Cough Drug's Future
November 16, 2023
Tickers
MRK
From Benzinga
FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca
November 16, 2023
From Benzinga
2 Healthcare Stocks That Could Make You Richer
November 15, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
